Promising New Alzheimer’s Drug
Eli Lilly, a large American pharmaceutical company, is claiming that their new drug may slow Alzheimer’s-related cognitive decline according to the results of a recent trial.
According to a recent article, the new drug is donanemab, “…an antibody designed to clear deposits of amyloid-β peptides that form plaques in the brains of patients with [Alzheimer’s Disease].”
You can read the full article here.
We are all hopeful that advancements like these will one day result in a cure for Alzheimer’s and other dementias! To learn more about memory care at Our Lady of Hope, click here.
